Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Unicycive Therapeutics, Inc. | Director | Series A-2 Prime Preferred Stock | 3.89K | $3.89M | $1,000.00 | Oct 9, 2024 | By Vivo Opportunity Fund Holdings L.P. |
GERON CORP | Director | Common Stock | 1.97K | $4.49K | $2.28 | Dec 29, 2023 | Direct |
Unicycive Therapeutics, Inc. | Director | Common Stock | 9.97M | Oct 9, 2024 | By Vivo Opportunity Fund Holdings L.P. | ||
GERON CORP | Director | Stock Option (right to buy) | 180K | May 9, 2024 | Direct | ||
Sierra Oncology, Inc. | Director | Common Stock | 0 | $55.00 | Jul 1, 2022 | By: Vivo Opportunity Fund Holdings, L.P. | |
Sierra Oncology, Inc. | Director | Series A Warrant | 0 | Jul 1, 2022 | By: Vivo Opportunity Fund Holdings, L.P. | ||
Sierra Oncology, Inc. | Director | Stock Option (right to buy) | 0 | Jul 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
UNCY | Unicycive Therapeutics, Inc. | Oct 9, 2024 | 2 | -$2.7M | 4 | Oct 10, 2024 | Director |
GERN | GERON CORP | May 9, 2024 | 1 | $0 | 4 | May 10, 2024 | Director |
GERN | GERON CORP | Dec 29, 2023 | 1 | $0 | 4 | Jan 3, 2024 | Director |
GERN | GERON CORP | Nov 26, 2023 | 1 | $0 | 4 | Nov 28, 2023 | Director |
GERN | GERON CORP | Nov 26, 2023 | 0 | $0 | 3 | Nov 28, 2023 | Director |
UNCY | Unicycive Therapeutics, Inc. | Sep 5, 2023 | 1 | $0 | 4 | Sep 7, 2023 | Director |
UNCY | Unicycive Therapeutics, Inc. | Jul 11, 2023 | 6 | -$8.08M | 4 | Jul 13, 2023 | Director |
UNCY | Unicycive Therapeutics, Inc. | Mar 8, 2023 | 1 | $8.08M | 4 | Mar 9, 2023 | Director |
UNCY | Unicycive Therapeutics, Inc. | Mar 8, 2023 | 0 | $0 | 3 | Mar 8, 2023 | Director |
SRRA | Sierra Oncology, Inc. | Jul 1, 2022 | 5 | -$150M | 4 | Jul 1, 2022 | Director |
SRRA | Sierra Oncology, Inc. | Jan 31, 2022 | 1 | $21.6M | 4 | Jan 31, 2022 | Director, 10%+ Owner |
SRRA | Sierra Oncology, Inc. | Jan 26, 2022 | 2 | -$12.9M | 4 | Jan 28, 2022 | Director, 10%+ Owner |
SRRA | Sierra Oncology, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director, 10%+ Owner |